Interaction between current vitamin D supplementation and menopausal hormone therapy use on breast cancer risk: evidence from the E3N cohort.
Am J Clin Nutr. 2015 Sep 9. pii: ajcn104323. [Epub ahead of print]
Cadeau C1, Fournier A1, Mesrine S1, Clavel-Chapelon F1, Fagherazzi G1, Boutron-Ruault MC2.
Data based on questionnaire
Vitamin D and Calcium dose size is not specified
See also VitaminDWiki
- Overview Breast Cancer and Vitamin D contains the following summary and sections
-
25 Meta-analyses of Vitamin D and Breast Cancer
example: 2X reduction of deaths from Breast Cancer if have enough Vitamin D.- Appears that having lots of Vitamin D will reduce by 3 X the chance of Breast Cancer
wonder just how much more proof is needed- Breast Cancer 4X more likely if have poor genes
- Cancer - Breast category listing has
259 items along with related searches - Breast Cancer treatment – Vitamin D was the most-popular supplement – Jan 2023
- Breast Cancer again associated with low vitamin D – 15th meta-analysis Sept 2020
- Vitamin D reduced Breast Cancer mortality in 9 out of 9 studies, yet still no consensus – April 2019
- Vitamin D both prevents and treats Breast Cancer – 2019
See also web
- Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study 2008
Clipped from abstract “The association was stronger in women never using menopausal hormone therapy (HT) compared with past and current users”
No such attachment on this page
BACKGROUND:
Experimental studies suggest protective effects of vitamin D on breast carcinogenesis, particularly on estrogen receptor-positive tumors. Epidemiologic data are less conclusive.OBJECTIVE:
Our objective was to investigate the association between postmenopausal breast cancer risk and current or past vitamin D supplementation overall and according to the use of menopausal hormone therapy (MHT).DESIGN:
Between 1995 and 2008, 2482 invasive breast cancer cases were diagnosed among 57,403 postmenopausal women from the E3N prospective cohort during 581,085 person-years. Vitamin D supplementation was assessed from biennially self-administered questionnaires sent in 1995, 2000, 2002, and 2005 and from medico-administrative data on drug reimbursements since 2004. Multivariable HRs for primary invasive breast cancer and 95% CIs were estimated by using Cox models.RESULTS:
A decreased postmenopausal breast cancer risk was associated with current (HR: 0.82; 95% CI: 0.69, 0.97) but not past (HR: 1.10; 95% CI: 0.92, 1.31) vitamin D supplementation (P-homogeneity = 0.02). The association with current vitamin D supplementation differed according to MHT use: ever users (HR: 0.74; 95% CI: 0.60, 0.90) and never users (HR: 1.13; 95% CI: 0.89, 1.56); P-homogeneity = 0.02.CONCLUSIONS:
In this observational study, current vitamin D supplementation, mostly taken daily and combined with calcium, was associated with a decreased postmenopausal breast cancer risk in MHT users. These findings should be confirmed before considering vitamin D supplementation to partly balance the MHT-associated increased breast cancer risk.© 2015 American Society for Nutrition.
PMID: 26354532
Publisher wants $40 for the PODF
Breast Cancer: 26 percent less risk if menopausal hormone therapy plus vitamin D – Sept 2015(Cached) Printer Friendly Follow this page for updates4606 visitors, last modified 12 Sep, 2015, This page is in the following categories (# of items in each category) - Appears that having lots of Vitamin D will reduce by 3 X the chance of Breast Cancer